New York State Common Retirement Fund’s Elicio Therapeutics ELTX Stock Holding History
Bought
Maintained
Sold
Other funds holding ELTX
KCM
IC
New York State Common Retirement Fund's ELTX Position: Q2 2026 in Review
New York State Common Retirement Fund opened a new position in Elicio Therapeutics (ELTX) in Q2 2026: 14,200 shares worth $55.5K. The stake represents ﹤0.01% of the portfolio and ranks #2967 among its holdings. This is a return to the name: New York State Common Retirement Fund previously reported a position in ELTX as recently as Q2 2022.
New York State Common Retirement Fund first reported a position in ELTX in Q1 2021 and has held it in 7 quarters since. The position peaked at $75K in Q2 2021. 48 funds tracked by Wall St. Rank hold ELTX as of Q2 2026.
- New York State Common Retirement Fund held 14,200 shares of Elicio Therapeutics worth $55.5K as of Q2 2026.
- Elicio Therapeutics was a new New York State Common Retirement Fund position in Q2 2026.
- Elicio Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2967 holding.
- New York State Common Retirement Fund first reported a position in Elicio Therapeutics in Q1 2021 and has held it in 7 quarters since.
- New York State Common Retirement Fund's Elicio Therapeutics position peaked at $75K in Q2 2021.
- 48 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q2 2026.
Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.